Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeNCT05740007IRWDPhase 2Terminated2025-01-23Actual
Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal HemoglobinuriaNCT05741346BioCryst PharmaceuticalsPhase 2Terminated2025-01-31Actual
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)NCT05742607Innate PharmaPhase 2Recruiting2027-06Estimated
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's DiseaseNCT05744401ALECPhase 2Terminated2025-01-31Actual
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseNCT05759208OKYOPhase 2Completed2023-12-15Actual
Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)NCT05764239SynlogicPhase 3Terminated2024-03-15Actual
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCMNCT05767346CytokineticsPhase 3Completed2025-02-28Actual
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaNCT05768854RAREPhase 3Active not recruiting2025-10-23Actual
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication RegimenNCT05769608MLYSPhase 2Completed2025-01-15Actual
A Study of CDX-0159 in Patients With Eosinophilic EsophagitisNCT05774184Celldex TherapeuticsPhase 2Completed2025-06-04Actual
A Trial of Setmelanotide in Acquired Hypothalamic ObesityNCT05774756RYTMPhase 3Active not recruiting2025-03-18Actual
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)NCT05786573Zenas BioPharma (USA), LLCPhase 3Active not recruiting2026-06-30Estimated
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated
AD816 Crossover StudyNCT05793684ApnimedPhase 2Completed2023-11-09Actual
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisNCT05796765MDXGPhase 2Terminated2023-12-15Actual
Safety and Efficacy of VDMN-21 Patch in Subjects With Common WartsNCT05799157MANEPhase 2Completed2025-02-25Actual
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)NCT05811247ApnimedPhase 3Completed2025-05-07Actual
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)NCT05813275ApnimedPhase 3Completed2025-03-10Actual
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)NCT05814757OCULPhase 2Completed2024-05-22Actual
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)NCT05818553Praxis Precision MedicinesPhase 2, Phase 3Active not recruiting2025-11-12Actual
Study of TP-04 in Participants With Papulopustular RosaceaNCT05838170TARSPhase 2Completed2023-11-13Actual
Study of ADI-PEG 20 Versus Placebo in Subjects With NASHNCT05842512Polaris GroupPhase 2Recruiting2027-12-31Estimated
Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy InfantsNCT05844423PCVXPhase 2Completed2025-08-25Actual
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerNCT05848011MacroGenicsPhase 2Completed2026-02-19Actual
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)NCT05854784Clinuvel Pharmaceuticals LimitedPhase 2Completed2023-12-28Actual
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMANCT05855083Omeros CorporationPhase 2Recruiting2025-12Estimated
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusNCT05856448LKFTPhase 2Completed2025-10-08Actual
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgANNCT05856760TVTXPhase 2Completed2024-10-14Actual
A Biomarker Study of ATH434 in Participants With MSANCT05864365Alterity TherapeuticsPhase 2Completed2025-02-26Actual
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1NCT05870748STROPhase 2, Phase 3Terminated2025-08-26Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.